However, to our knowledge, there have been no population‐based prospective longitudinal studies that have comprehensively assessed the association between plasma levels of Aβ42/40, p‐τ181, GFAP, and NfL and the risk of developing dementia. The gene discussed is GFAP; the disease is dementia.